SCHEMBL12200733

SCHEMBL12200733

CC(=O)N(C)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 19/20 0.74
CHRM2 P08172 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13590174 0.91 CHRM3 (0.78) CHRM3
SCHEMBL24906759 0.88 CHRM3 (0.68) CHRM3CHRM2
SCHEMBL13590238 0.87 CHRM3 (0.87) CHRM3
SCHEMBL13590286 0.87 CHRM3 (0.73) CHRM3
SCHEMBL381121 0.87 CHRM3 (0.67) CHRM3
SCHEMBL356773 0.87 CHRM3 (0.67) CHRM3CHRM2
SCHEMBL13590493 0.87 CHRM3 (0.79) CHRM3
SCHEMBL266010 0.86 CHRM3 (0.71) CHRM3
SCHEMBL355992 0.86 CHRM2 (0.79) CHRM3CHRM2
SCHEMBL381227 0.86 CHRM3 (0.67) CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8034946-B2 Biphenyl compounds useful as muscarinic receptor antagonists THERAVANCE, INC. (US) 2011-10-11 US disclosed
US-8034946-B2 Biphenyl compounds useful as muscarinic receptor antagonists THERAVANCE, INC. (US) 2011-10-11 US disclosed